Table of Contents
Volume 5 | Issue 5
Publication Date: January 2006- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
312 |
Clinical Colorectal Cancer: New Advances in Screening Edward Chu |
|
Researches in Brief | ||
318-320 |
Radiofrequency Ablation for Patients with Colorectal Cancer and Unresectable Liver Metastasis Tara Beers Gibson, Carlos Becerra, Edward Chu |
|
321-323 |
Polymorphisms in the Thymidylate Synthase Gene Predict Response to 5-Fluorouracil Therapy in Colorectal Cancer Tara Beers Gibson, Carlos Becerra, Edward Chu |
|
324-326 |
The Role of Immunotherapy in the Treatment of Colorectal Cancer G. Kesava Reddy, Carlos R. Bercerra, Edward Chu |
|
Comprehensive Review | ||
327-337 |
Management of Less Common Tumors of the Colon, Rectum, and Anus Madison Cuffy, Farshad Abir, Walter E. Longo |
|
Original Contributions | ||
338-343 |
Colorectal Cancer Screening Using Stool DNA Analysis in Clinical Practice: Early Clinical Experience with Respect to Patient Acceptance and Colonoscopic Follow-up of Abnormal Tests Barry M. Berger, Paul C. Schroy, III, Jennifer L. Rosenberg, Myla Lai-Goldman, Marcia Eisenberg, Trisha Brown, Robert B. Rochelle, Paul R. Billings |
|
344-349 |
Expression and Clinical Significance of Methylenetetrahydrofolate Reductase in Patients with Colorectal Cancer Elisabeth Odin, Yvonne Wettergren, Göran Carlsson, Peter V. Danenberg, Angelo Termini, Roger Willén, Bengt Gustavsson |
|
350-353 |
Clinical Significance of Immunohistochemical Expression of Hypoxia-Inducible Factor–1α as a Prognostic Marker in Rectal Adenocarcinoma Xue-guan Lu, Chun-gen Xing, Yi-zhong Feng, Jie Chen, Chong Deng |
|
354-358 |
A Retrospective Study of Coagulation Abnormalities in Patients Receiving Concomitant Capecitabine and Warfarin Heather R. Shah, Leslie Ledbetter, Robert Diasio, M. Wasif Saif |
|
Case Report | ||
359-362 |
Is Capecitabine Safe in Patients with Gastrointestinal Cancer and Dihydropyrimidine Dehydrogenase Deficiency? M. Wasif Saif, Robert Diasio |
|
Current Trials | ||
363-367 |
A Phase III Randomized, Open-Label, Controlled Trial of Chemotherapy and Bevacizumab with or Without Panitumumab in the First-Line Treatment of Patients with Metastatic Colorectal Cancer Zev Wainberg, J. Randolph Hecht |
|
368-371 |
A Phase II Study of Active Immunotherapy with PANVAC™ or Autologous, Cultured Dendritic Cells Infected with PANVAC™ After Complete Resection of Hepatic Metastases of Colorectal Carcinoma Emil Lou, John Marshall, Mebea Aklilu, David Cole, David Chang, Michael Morse |
|
Clinical Trials | ||
376 |
Selected Clinical Trials in Colorectal Cancer CIG Media Group |
|